New hope for tough blood cancer: trial tests Two-Drug attack
Disease control
Not yet recruiting
This study is testing a new combination of two drugs, mitoxantrone liposome and enlonstobart, for adults with a type of blood cancer called peripheral T-cell lymphoma that has come back or not responded to previous treatments. The main goals are to find the safest and most effect…
Phase: PHASE1, PHASE2 • Sponsor: Sun Yat-Sen University Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:27 UTC